Companies Dominating the Zoster Treatment Landscape
- Novartis AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Valeant Pharmaceuticals North America, LLC
- Merck & Co., Inc.
- Abbott Laboratories
- Teva Pharmaceutical Ltd
- Camber Pharmaceuticals, Inc.
- Gilead Sciences Inc.
- Mylan NV
- GlaxoSmithKline plc
- Maruho Co. Ltd.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Zoster Treatment Market size is poised to witness over 13.8% CAGR during the forecast period i.e., between 2025-2037.
The market growth is driven by high prevalence of zoster globally and rising introduction of vaccines and medications for self-treatment.
Asia Pacific industry is estimated to account for largest revenue share by 2037, propelled by growing occurrence of herpes zoster, and rising initiatives by governmental and non-governmental organizations associated with vaccination drives.
The major players in the market are Valeant Pharmaceuticals North America, LLC, Merck & Co., Inc., Abbott Laboratories, Teva Pharmaceutical Ltd, and others.
